Sunesis Pharmaceuticals Reports Third Quarter 2011 Financial Results – Boston Globe

The VALOR logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8774   About Vosaroxin Vosaroxin is a first-in-class anti-cancer quinolone derivative,(AQD), a class of compounds that has not been used previously for the …